In this work, a surface plasmon resonance (SPR) biosensor based on two-dimensional transition metal dichalcogenides (TMDCs) is proposed to improve the biosensor’s sensitivity. In this sensor, different kinds of two-dimensional TMDCs are coated on both surfaces of metal film. By optimizing the structural parameters, the angular sensitivity can reach as high as 315.5 Deg/RIU with 7-layers WS2 and 36 nm Al thin film, which is 3.3 times of the conventional structure based on single Al thin film. We also obtain maximum phase sensitivity (3.85 × 106 Deg/RIU) with bilayer WS2 and 35 nm Al thin film. The phase sensitivity can be further improved by employing Ag and removing air layer. The proposed configuration is of great potential for biochemical sensing.
In order to improve the performance of surface plasmon resonance (SPR) biosensor, the structure based on two-dimensional (2D) of graphene and transition metal dichalcogenides (TMDCs) are proposed to greatly enhance the Goos-Hänchen (GH) shift. It is theoretically proved that GH shift can be significantly enhanced in SPR structure coated with gold (Au)-indium tin oxide (ITO)-TMDCs-graphene heterostructure. In order to realize high GH shifts, the number of TMDCs and graphene layer are optimized. The highest GH shift (−801.7 λ) is obtained by Au-ITO-MoSe2-graphene hybrid structure with MoSe2 monolayer and graphene bilayer, respectively. By analyzing the GH variation, the index sensitivity of such configuration can reach as high as 8.02 × 105 λ/RIU, which is 293.24 times of the Au-ITO structure and 177.43 times of the Au-ITO-graphene structure. The proposed SPR biosensor can be widely used in the precision metrology and optical sensing.
The performance of conventional gas sensors based on light absorption in the mid-infrared (MIR) faces the challenges of the high cost and low efficiency of photodetection at these wavelengths. In this paper, a nonlinear gas sensor based on third-harmonic generation (THG) in cascaded chalcogenide microfibers is proposed. In the first microfiber section, the input MIR light with "fingerprint" frequency has shown the ability for a large amount of gas absorption. The second microfiber section is used for THG pumped by the residual MIR light. In this process, the sensing signal is converted to the near-infrared region, and the power variation caused by the absorption is amplified due to the nonlinear relation between pump and harmonic signals. According to our analysis, the lowest methane concentration of 7.4 × 10 −8 can be detected at a practically drawable Ae 2 Se 3 microfiber length of 1 cm. Compared to direct MIR gas sensing, cascaded microfiber sensing has the advantages of improved sensing performance and also shorter absorption length.
Surface plasmon resonance (SPR) with two-dimensional (2D) materials is proposed to enhance the sensitivity of sensors. A novel Goos–Hänchen (GH) shift sensing scheme based on blue phosphorene (BlueP)/transition metal dichalogenides (TMDCs) and graphene structure is proposed. The significantly enhanced GH shift is obtained by optimizing the layers of BlueP/TMDCs and graphene. The maximum GH shift of the hybrid structure of Ag-Indium tin oxide (ITO)-BlueP/WS2–graphene is −2361λ with BlueP/WS2 four layers and a graphene monolayer. Furthermore, the GH shift can be positive or negative depending on the layer number of BlueP/TMDCs and graphene. For sensing performance, the highest sensitivity of 2.767 × 107λ/RIU is realized, which is 5152.7 times higher than the traditional Ag-SPR structure, 2470.5 times of Ag-ITO, 2159.2 times of Ag-ITO-BlueP/WS2, and 688.9 times of Ag-ITO–graphene. Therefore, such configuration with GH shift can be used in various chemical, biomedical and optical sensing fields.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.